Literature DB >> 16859948

Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife robotic system.

I C Gibbs1.   

Abstract

The Cyberknife is an image-guided robotic radiosurgery system. The image guidance system includes a kilovoltage X-ray imaging source and amorphous silica detectors. The radiation delivery device is a mobile X-band linear accelerator mounted onto a robotic arm. Through a highly complex interplay between the image guidance system, an automated couch, and the high-speed linear accelerator, near real-time tracking of the target is achieved. The Cyberknife gained Federal Drug Administration clearance in the United States in 2001 for treatment of tumors "anywhere in the body where radiation treatment is indicated." Because the Cyberknife system does not rely on rigid fixation of a stereotactic frame, tumors outside of the intracranial compartment, even those tumors that move with respiration can be treated with a similar degree of ease as intracranial targets. A description of the Cyberknife technology and a review of some of the current intracranial and extracranial applications are detailed herein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16859948     DOI: 10.1016/j.canrad.2006.05.013

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  11 in total

Review 1.  Alternatives to surgery in early stage disease-stereotactic body radiotherapy.

Authors:  Meredith Elana Giuliani; Andrea Bezjak
Journal:  Transl Lung Cancer Res       Date:  2013-10

2.  CyberKnife for Treatment of Vestibular Schwannoma: A Meta-analysis.

Authors:  Hossein Mahboubi; Ronald Sahyouni; Omid Moshtaghi; Kent Tadokoro; Yaser Ghavami; Kasra Ziai; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-25       Impact factor: 3.497

3.  Public interest in stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) in the United States.

Authors:  Timothy D Malouff; Danushka Seneviratne; William C Stross; Stephen Ko; Katherine Tzou; Daniel M Trifiletti; Laura A Vallow
Journal:  J Radiosurg SBRT       Date:  2020

4.  The role of stereotactic radiosurgery in metastasis to the spine.

Authors:  Seil Sohn; Chun Kee Chung
Journal:  J Korean Neurosurg Soc       Date:  2012-01-31

5.  Stereotactic ablative radiotherapy with CyberKnife for advanced thymic carcinoma: a case report.

Authors:  C Y Fan; W Y Huang; Y M Jen; M J Lin; K T Lin
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

6.  Design and testing of a simulation framework for dosimetric motion studies integrating an anthropomorphic computational phantom into four-dimensional Monte Carlo.

Authors:  M Riboldi; G T Y Chen; G Baroni; H Paganetti; J Seco
Journal:  Technol Cancer Res Treat       Date:  2008-12

7.  Simultaneous tumor and surrogate motion tracking with dynamic MRI for radiation therapy planning.

Authors:  Seyoun Park; Rana Farah; Steven M Shea; Erik Tryggestad; Russell Hales; Junghoon Lee
Journal:  Phys Med Biol       Date:  2018-01-11       Impact factor: 3.609

8.  Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy.

Authors:  Zsolt Levente Janvary; Nicolas Jansen; Veronique Baart; Magali Devillers; David Dechambre; Eric Lenaerts; Laurence Seidel; Nicole Barthelemy; Patrick Berkovic; Akos Gulyban; Ferenc Lakosi; Zsolt Horvath; Philippe A Coucke
Journal:  Radiol Oncol       Date:  2017-04-03       Impact factor: 2.991

9.  Initial clinical experience with frameless optically guided stereotactic radiosurgery/radiotherapy in pediatric patients.

Authors:  Sassan Keshavarzi; Hal Meltzer; Sharona Ben-Haim; Charles Benjamin Newman; Joshua D Lawson; Michael L Levy; Kevin Murphy
Journal:  Childs Nerv Syst       Date:  2009-03-27       Impact factor: 1.475

10.  Radiochromic film based dosimetry of image-guidance procedures on different radiotherapy modalities.

Authors:  Ahmad Nobah; Saad Aldelaijan; Slobodan Devic; Nada Tomic; Jan Seuntjens; Mohammed Al-Shabanah; Belal Moftah
Journal:  J Appl Clin Med Phys       Date:  2014-11-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.